1st Quarter - Report

ABIOMED, INC for ABIOMED, INC

Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the implementation of the FDA Medical Device User Fee Agreement Issues related to heart recovery Education on CMS coverage for breakthrough technologies, HR 1691 Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization Issues related to medical device supply chain and sterilization Issues related to healthcare work force development

LobbyistCovered position, as disclosed
DANIELLE MITCHELL Office of Representative Gwen Graham (D-FL), Intern, 8/2016-12/2016 Horizon Therapetuics, Fellow, 6/2017-10/2017 California Life Science Association CLSA), Manager GA, 10/2017-4/2021
MELISSA DODSON SCHOOLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1691 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.